Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs

References

• Gram H, Marconi LA, Barbas CFs3rd, Collet TA, Lerner RA, Kang AS. In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library. Proc Natl Acad Sci U S A. 1992;89(8):1–14. doi:10.1073/pnas.89.8.3576.
   PubMed Web of Science ®Google Scholar
• Daugherty PS, Chen G, Iverson BL, Georgiou G. Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies. Proc Natl Acad Sci U S A. 2000;97:2029–34. doi:10.1073/pnas.030527597.
   PubMed Web of Science ®Google Scholar
• Lou J, Geren I, Garcia-Rodriguez C, Forsyth CM, Wen W, Knopp K, Brown J, Smith T, Smith LA, Marks JD, et al. Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating. Protein Eng Des Sel. 2010;23:311–19. doi:10.1093/protein/gzq001.
   PubMed Web of Science ®Google Scholar
• Park SG, Lee JS, Je EY, Kim IJ, Chung JH, Choi IH. Affinity maturation of natural antibody using a chain shuffling technique and the expression of recombinant antibodies in Escherichia coli. Biochem Biophys Res Commun. 2000;275:553–57. doi:10.1006/bbrc.2000.3336.
   PubMed Web of Science ®Google Scholar
• Marks JD, Griffiths AD, Malmqvist M, Clackson TP, Bye JM, Winter G. By-passing immunization: building high affinity human antibodies by chain shuffling. Biotechnology (N Y). 1992;10:779–83. doi:10.1038/nbt0792-779.
   PubMedGoogle Scholar
• Tiller KE, Chowdhury R, Li T, Ludwig SD, Sen S, Maranas CD, Tessier PM. Facile affinity maturation of antibody variable domains using natural diversity mutagenesis. Front Immunol. 2017;8:986. doi:10.3389/fimmu.2017.00986.
   PubMed Web of Science ®Google Scholar
• Barderas R, Desmet J, Timmerman P, Meloen R, Casal JI. Affinity maturation of antibodies assisted by in silico modeling. Proc Natl Acad Sci U S A. 2008;105:9029–34. doi:10.1073/pnas.0801221105.
   PubMed Web of Science ®Google Scholar
• Rajpal A, Beyaz N, Haber L, Cappuccilli G, Yee H, Bhatt RR, et al. A general method for greatly improving the affinity of antibodies by using combinatorial libraries. Proc Natl Acad Sci U S A. 2005;102:8466–71. doi:10.1073/pnas.0503543102.
   PubMed Web of Science ®Google Scholar
• Schier R, Bye J, Apell G, McCall A, Adams GP, Malmqvist M, Weiner LM, Marks JD. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J Mol Biol. 1996;255:28–43. doi:10.1006/jmbi.1996.0004.
   PubMed Web of Science ®Google Scholar
• Schier R, Marks JD. Efficient in vitro affinity maturation of phage antibodies using BIAcore guided selections. Hum Antibodies Hybridomas. 1996;7:97–105. doi:10.3233/HAB-1996-7302.
   PubMedGoogle Scholar
• Yang WP, Green K, Pinz-Sweeney S, Briones AT, Burton DR, Barbas CF. 3rd. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol. 1995;254:392–403. doi:10.1006/jmbi.1995.0626.
   PubMed Web of Science ®Google Scholar
• Boder ET, Midelfort KS, Wittrup KD. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc Natl Acad Sci USA. 2000;97:10701–05. doi:10.1073/pnas.170297297.
   PubMed Web of Science ®Google Scholar
• Low NM, Holliger PH, Winter G. Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain. J Mol Biol. 1996;260:359–68. doi:10.1006/jmbi.1996.0406.
   PubMed Web of Science ®Google Scholar
• Lamdan H, Gavilondo JV, Munoz Y, Pupo A, Huerta V, Musacchio A, Pérez L, Ayala M, Rojas G, Balint RF, et al. Affinity maturation and fine functional mapping of an antibody fragment against a novel neutralizing epitope on human vascular endothelial growth factor. Mol Biosyst. 2013;9:2097–106. doi:10.1039/c3mb70136k.
   PubMed Web of Science ®Google Scholar
• Schier R, McCall A, Adams GP, Marshall KW, Merritt H, Yim M, Crawford RS, Weiner LM, Marks C, Marks JD, et al. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J Mol Biol. 1996;263:551–67. doi:10.1006/jmbi.1996.0598.
   PubMed Web of Science ®Google Scholar
• Chan DTY, Jenkinson L, Haynes SW, Austin M, Diamandakis A, Burschowsky D, Seewooruthun C, Addyman A, Fiedler S, Ryman S, et al. Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation. Proc Natl Acad Sci U S A. 2020;117:16949–60. doi:10.1073/pnas.1919565117.
   PubMed Web of Science ®Google Scholar
• Hanes J, Jermutus L, Weber-Bornhauser S, Bosshard HR, Pluckthun A. Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc Natl Acad Sci U S A. 1998;95:14130–35. doi:10.1073/pnas.95.24.14130.
   PubMed Web of Science ®Google Scholar
• Hanes J, Schaffitzel C, Knappik A, Pluckthun A. Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display. Nat Biotechnol. 2000;18:1287–92. doi:10.1038/82407.
   PubMed Web of Science ®Google Scholar
• Ohlin M, Owman H, Mach M, Borrebaeck CAK. Light chain shuffling of a high affinity antibody results in a drift in epitope recognition. Mol Immunol. 1996;33:47–56. doi:10.1016/0161-5890(95)00123-9.
   PubMed Web of Science ®Google Scholar
• Julian MC, Lee CC, Tiller KE, Rabia LA, Day EK, Schick AJ, et al. 3rd Co-evolution of affinity and stability of grafted amyloid-motif domain antibodies. Protein Eng Des Sel. 2015;28:339–50. doi:10.1093/protein/gzv050.
   PubMed Web of Science ®Google Scholar
• Chou K-C, Némethy G, Pottle M, Scheraga HA. Energy of stabilization of the right-handed βαβ crossover in proteins. J Mol Biol. 1989;205:241–49. doi:10.1016/0022-2836(89)90378-1.
   PubMed Web of Science ®Google Scholar
• Du Q, Wei D, Chou K-C. Correlations of amino acids in proteins. Peptides. 2003;24:1863–69. doi:10.1016/j.peptides.2003.10.012.
   PubMed Web of Science ®Google Scholar
• Teixeira AAR, Erasmus MF, D’Angelo S, Naranjo L, Ferrara F, Leal-Lopes C, Durrant O, Galmiche C, Morelli A, Scott-Tucker A, et al. Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries. MAbs. 2021;13:1980942. doi:10.1080/19420862.2021.1980942.
   PubMed Web of Science ®Google Scholar
• Ferrara F, Erasmus MF, D’Angelo S, Leal-Lopes C, Teixeira AA, Choudhary A, et al. A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies. Nat Commun. pp.13. 2022. doi:10.1038/s41467-021-27594-w
   PubMed Web of Science ®Google Scholar
• Erasmus MF, D’Angelo S, Ferrara F, Naranjo L, Teixeira AA, Buonpane R, et al. A single donor is sufficient to produce a highly functional in vitro antibody library. Commun Biol. pp.4. 2021. doi:10.1038/s42003-020-01536-6
   PubMed Web of Science ®Google Scholar
• Sydow JF, Lipsmeier F, Larraillet V, Hilger M, Mautz B, Molhoj M, et al. Structure-based prediction of asparagine and aspartate degradation sites in antibody variable regions. PLoS One. 2014;9:e100736. doi:10.1371/journal.pone.0100736.
   PubMed Web of Science ®Google Scholar
• Kelly RL, Le D, Zhao J, Wittrup KD. Reduction of nonspecificity motifs in synthetic antibody libraries. J Mol Biol. 2018;430:119–30. doi:10.1016/j.jmb.2017.11.008.
   PubMed Web of Science ®Google Scholar
• Kumar S, Singh SK. Developability of Biotherapeutics: computational approaches. Florida (US): CRC Press; 2016.
   Google Scholar
• Gavel Y, von Heijne G. Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Eng. 1990;3:433–42. doi:10.1093/protein/3.5.433.
   PubMedGoogle Scholar
• Bethea D, Wu SJ, Luo J, Hyun L, Lacy ER, Teplyakov A, Jacobs SA, O’Neil KT, Gilliland GL, Feng Y, et al. Mechanisms of self-association of a human monoclonal antibody CNTO607. Protein Eng Des Sel. 2012;25:531–37. doi:10.1093/protein/gzs047.
   PubMed Web of Science ®Google Scholar
• Wu SJ, Luo J, O’Neil KT, Kang J, Lacy ER, Canziani G, Baker A, Huang M, Tang QM, Raju TS, et al. Structure-based engineering of a monoclonal antibody for improved solubility. Protein Eng Des Sel. 2010;23:643–51. doi:10.1093/protein/gzq037.
   PubMed Web of Science ®Google Scholar
• Vlasak J, Ionescu R. Fragmentation of monoclonal antibodies. MAbs. 2011;3:253–63. doi:10.4161/mabs.3.3.15608.
   PubMed Web of Science ®Google Scholar
• Boder ET, Wittrup KD. Optimal screening of surface-displayed polypeptide libraries. Biotechnol Prog. 1998;14:55–62. doi:10.1021/bp970144q.
   PubMed Web of Science ®Google Scholar
• VanAntwerp JJ, Wittrup KD. Fine affinity discrimination by yeast surface display and flow cytometry. Biotechnol Prog. 2000;16:31–37. doi:10.1021/bp990133s.
   PubMed Web of Science ®Google Scholar
• Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res. 2004;14:1188–90. doi:10.1101/gr.849004.
   PubMed Web of Science ®Google Scholar
• Lundström I. Real-time biospecific interaction analysis. Biosens Bioelectron. 1994;9:725–36. doi:10.1016/0956-5663(94)80071-5.
   Web of Science ®Google Scholar
• Kang AS, Jones TM, Burton DR. Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries. Proc Natl Acad Sci U S A. 1991;88:11120–23. doi:10.1073/pnas.88.24.11120.
   PubMed Web of Science ®Google Scholar
• Hawkins RE, Russell SJ, Winter G. Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J Mol Biol. 1992;226:889–96. doi:10.1016/0022-2836(92)90639-2.
   PubMed Web of Science ®Google Scholar
• Cannon DA, Shan L, Du Q, Shirinian L, Rickert KW, Rosenthal KL, Korade M, van Vlerken-Ysla LE, Buchanan A, Vaughan TJ, et al. Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design. PLoS Comput Biol. 2019;15:e1006980. doi:10.1371/journal.pcbi.1006980.
   PubMed Web of Science ®Google Scholar
• Hu D, Hu S, Wan W, Xu M, Du R, Zhao W, Gao X, Liu J, Liu H, Hong J, et al. Effective optimization of antibody affinity by phage display integrated with high-throughput DNA synthesis and sequencing technologies. PLoS One. 2015;10:e0129125. doi:10.1371/journal.pone.0129125.
   PubMed Web of Science ®Google Scholar
• Frigotto L, Smith M, Brankin C, Sedani A, Cooper S, Kanwar N, Evans D, Svobodova S, Baar C, Glanville J, et al. Codon-Precise, synthetic, antibody fragment libraries built using automated hexamer codon additions and validated through next generation sequencing. Antibodies. 2015;4:88–102. doi:10.3390/antib4020088.
   Google Scholar
• Thakkar S, Nanaware-Kharade N, Celikel R, Peterson EC, Varughese KI. Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering. Sci Rep. 2014;4:3673. doi:10.1038/srep03673.
   PubMed Web of Science ®Google Scholar
• Votsmeier C, Plittersdorf H, Hesse O, Scheidig A, Strerath M, Gritzan U, Pellengahr K, Scholz P, Eicker A, Myszka D, et al. Femtomolar Fab binding affinities to a protein target by alternative CDR residue co-optimization strategies without phage or cell surface display. MAbs. 2012;4:341–48. doi:10.4161/mabs.19981.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Munoz A, Bokma E, O’Shea D, Minton K, Strain M, Vousden K, et al. Tailored amino acid diversity for the evolution of antibody affinity. MAbs. 2012;4:4. doi:10.4161/mabs.4.1.18821.
   PubMed Web of Science ®Google Scholar
• Yang GH, Yoon SO, Jang MH, Hong HJ. Affinity maturation of an anti-hepatitis B virus PreS1 humanized antibody by phage display. J Microbiol. 2007;45:528–33.
   PubMed Web of Science ®Google Scholar
• Lippow SM, Wittrup KD, Tidor B. Computational design of antibody-affinity improvement beyond in vivo maturation. Nat Biotechnol. 2007;25:1171–76. doi:10.1038/nbt1336.
   PubMed Web of Science ®Google Scholar
• Garcia-Rodriguez C, Levy R, Arndt JW, Forsyth CM, Razai A, Lou J, Geren I, Stevens RC, Marks JD. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Nat Biotechnol. 2007;25:107–16. doi:10.1038/nbt1269.
   PubMed Web of Science ®Google Scholar
• Lu D, Shen J, Vil MD, Zhang H, Jimenez X, Bohlen P, Witte L, Zhu Z. Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity. J Biol Chem. 2003;278:43496–507. doi:10.1074/jbc.M307742200.
   PubMed Web of Science ®Google Scholar
• Rader C, Popkov M, Neves JA, Barbas CF. 3rd. Integrin alpha(v)beta3 targeted therapy for Kaposi’s sarcoma with an in vitro evolved antibody. FASEB J. 2002;16:2000–02. doi:10.1096/fj.02-0281fje.
   PubMed Web of Science ®Google Scholar
• Wu H, Beuerlein G, Nie Y, Smith H, Lee BA, Hensler M, Huse WD, Watkins JD. Stepwise in vitro affinity maturation of Vitaxin, an α v β 3 -specific humanized mAb. Proc Natl Acad Sci U S A. 1998;95:6037–42. doi:10.1073/pnas.95.11.6037.
   PubMed Web of Science ®Google Scholar
• Hemminki A, Niemi S, Hoffren AM, Hakalahti L, Soderlund H, Takkinen K. Specificity improvement of a recombinant anti-testosterone Fab fragment by CDRIII mutagenesis and phage display selection. Protein Eng. 1998;11:311–19. doi:10.1093/protein/11.4.311.
   PubMedGoogle Scholar
• Thompson J, Pope T, Tung JS, Chan C, Hollis G, Mark G, et al. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity. J Mol Biol. 1996;256:77–88. doi:10.1006/jmbi.1996.0069.
   PubMed Web of Science ®Google Scholar
• Jackson JR, Sathe G, Rosenberg M, Sweet R. In vitro antibody maturation. Improvement of a high affinity, neutralizing antibody against IL-1 beta. J Immunol. 1995;154:3310–19.
   PubMed Web of Science ®Google Scholar
• Julian MC, Li L, Garde S, Wilen R, Tessier PM. Efficient affinity maturation of antibody variable domains requires co-selection of compensatory mutations to maintain thermodynamic stability. Sci Rep. 2017;7:45259. doi:10.1038/srep45259.
   PubMed Web of Science ®Google Scholar
• Kosuri S, Church GM. Large-scale de novo DNA synthesis: technologies and applications. Nat Methods. 2014;11:499–507. doi:10.1038/nmeth.2918.
   PubMed Web of Science ®Google Scholar
• Kosuri S, Eroshenko N, Leproust EM, Super M, Way J, Li JB, Church GM. Scalable gene synthesis by selective amplification of DNA pools from high-fidelity microchips. Nat Biotechnol. 2010;28:1295–99. doi:10.1038/nbt.1716.
   PubMed Web of Science ®Google Scholar
• Jain T, Sun T, Durand S, Hall A, Houston NR, Nett JH, Sharkey B, Bobrowicz B, Caffry I, Yu Y, et al. Biophysical properties of the clinical-stage antibody landscape. Proc Natl Acad Sci U S A. 2017;114:944–49. doi:10.1073/pnas.1616408114.
   PubMed Web of Science ®Google Scholar
• Tiller KE, Li L, Kumar S, Julian MC, Garde S, Tessier PM. Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs. J Biol Chem. 2017;292:16638–52. doi:10.1074/jbc.M117.783837.
   PubMed Web of Science ®Google Scholar
• Pepinsky RB, Silvian L, Berkowitz SA, Farrington G, Lugovskoy A, Walus L, Eldredge J, Capili A, Mi S, Graff C, et al. Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis. Protein Sci. 2010;19:954–66. doi:10.1002/pro.372.
   PubMed Web of Science ®Google Scholar
• Rosenfeld R, Alcalay R, Mechaly A, Lapidoth G, Epstein E, Kronman C, J Fleishman S, Mazor O. Improved antibody-based ricin neutralization by affinity maturation is correlated with slower off-rate values. Protein Eng Des Sel. 2017;30:611–17. doi:10.1093/protein/gzx028.
   PubMed Web of Science ®Google Scholar
• Hurlburt NK, Seydoux E, Wan YH, Edara SsVV, AB, Feng J, Feng J, Suthar MS, McGuire AT, Stamatatos L, Pancera M, et al. Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation. Nat Commun. 2020;11:5413. doi:10.1038/s41467-020-19231-9.
   PubMed Web of Science ®Google Scholar
• Akbar R, Robert PA, Pavlovic M, Jeliazkov JR, Snapkov I, Slabodkin A, Weber CR, Scheffer L, Miho E, Haff IH, et al. A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding. Cell Rep. 2021;34:108856. doi:10.1016/j.celrep.2021.108856.
   PubMed Web of Science ®Google Scholar
• Xu JL, Davis MM. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity. 2000;13:37–45. doi:10.1016/S1074-7613(00)00006-6.
   PubMed Web of Science ®Google Scholar
• Hemminki A, Niemi S, Hautoniemi L, Söderlund H, Takkinen K. Fine tuning of an anti-testosterone antibody binding site by stepwise optimisation of the CDRs. Immunotechnology. 1998;4:59–69. doi:10.1016/S1380-2933(98)00002-5.
   PubMedGoogle Scholar
• Traxlmayr MW, Shusta EV. Directed evolution of protein thermal stability using yeast surface display. Methods Mol Biol. 2017;1575:45–65.
   PubMedGoogle Scholar
• Darling RJ, Brault PA. Kinetic exclusion assay technology: characterization of molecular interactions. Assay Drug Dev Technol. 2004;2:647–57. doi:10.1089/adt.2004.2.647.
   PubMed Web of Science ®Google Scholar
• Kovaltsuk A, Leem J, Kelm S, Snowden J, Deane CM, Krawczyk K. Observed antibody space: a resource for data mining next-generation sequencing of antibody repertoires. J Immunol. 2018;201:2502–09. doi:10.4049/jimmunol.1800708.
   PubMed Web of Science ®Google Scholar
• Ye J, Ma N, Madden TL, Ostell JM. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 2013;41:W34–40. doi:10.1093/nar/gkt382.
   PubMed Web of Science ®Google Scholar
• Giudicelli V, Brochet X, Lefranc MP. IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. Cold Spring Harb Protoc. 2011;2011:695–715. doi:10.1101/pdb.prot5633.
   PubMedGoogle Scholar
• Kabat EA, Wu TT, Bilofsky H. Evidence supporting somatic assembly of the DNA segments (minigenes), coding for the framework, and complementarity-determining segments of immunoglobulin variable regions. J Exp Med. 1979;149:1299–313. doi:10.1084/jem.149.6.1299.
   PubMed Web of Science ®Google Scholar
• Benatuil L, Perez JM, Belk J, Hsieh CM. An improved yeast transformation method for the generation of very large human antibody libraries. Protein Eng Des Sel. 2010;23:155–59. doi:10.1093/protein/gzq002.
   PubMed Web of Science ®Google Scholar
• Ferrara F, Naranjo LA, Kumar S, Gaiotto T, Mukundan H, Swanson B, et al. Using phage and yeast display to select hundreds of monoclonal antibodies: application to antigen 85, a tuberculosis biomarker. PLoS One. 2012;7:e49535. doi:10.1371/journal.pone.0049535.
   PubMed Web of Science ®Google Scholar